Free Trial

Mustang Bio (MBIO) Short Interest Ratio & Short Volume

$0.19
-0.02 (-9.59%)
(As of 05/28/2024 ET)

Mustang Bio Short Interest Data

Current Short Interest
247,200 shares
Previous Short Interest
82,200 shares
Change Vs. Previous Month
+200.73%
Dollar Volume Sold Short
$68,474.40
Short Interest Ratio
0.2 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
12,520,000 shares
Float Size
9,070,000 shares
Short Percent of Float
2.73%
Today's Trading Volume
12,929,290 shares
Average Trading Volume
3,561,786 shares
Today's Volume Vs. Average
363%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Mustang Bio ?

Sign up to receive the latest short interest report for Mustang Bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MBIO Short Interest Over Time

MBIO Days to Cover Over Time

MBIO Percentage of Float Shorted Over Time

Mustang Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024247,200 shares $68,474.40 +200.7%2.7%0.2 $0.28
4/30/202482,200 shares $20,385.60 -39.8%0.9%0.3 $0.25
4/15/2024136,500 shares $51,187.50 -23.3%1.8%0.7 $0.38
3/31/2024178,000 shares $185,120.00 -54.2%2.4%1.2 $1.04
3/15/2024389,000 shares $369,550.00 +828.4%5.1%2.7 $0.95
2/29/202441,900 shares $56,565.00 -1.9%0.6%0.3 $1.35
2/15/202442,700 shares $55,937.00 -15.6%0.6%0.8 $1.31
1/31/202450,600 shares $72,864.00 +58.6%0.7%0.8 $1.44
1/15/202431,900 shares $46,574.00 -53.0%0.4%0.3 $1.46
12/31/202367,800 shares $91,530.00 -18.2%1.0%0.7 $1.35
12/15/202382,900 shares $114,402.00 -4.5%1.2%0.8 $1.38
11/30/202386,800 shares $124,992.00 +15.9%1.4%1 $1.44
11/15/202374,900 shares $121,338.00 -59.9%1.2%1 $1.62
10/31/2023186,700 shares $306,188.00 +571.6%2.7%2.5 $1.64
10/15/202327,800 shares $46,426.00 -53.0%0.5%1.1 $1.67
9/30/202359,200 shares $122,544.00 +166.7%1.1%2.2 $2.07
9/15/202322,200 shares $55,944.00 -59.9%0.4%0.7 $2.52
8/31/202355,400 shares $175,618.00 +60.1%1.0%1.3 $3.17
8/15/202334,600 shares $131,480.00 -19.9%0.6%0.7 $3.80
7/31/202343,200 shares $224,640.00 -45.2%0.8%0.9 $5.20
7/15/202378,800 shares $409,760.00 +47.3%1.5%1.4 $5.20
6/30/202353,500 shares $332,235.00 -19.3%1.0%0.8 $6.21
6/15/202366,300 shares $484,653.00 +10.3%1.2%0.9 $7.31
5/31/202360,100 shares $384,039.00 -38.2%1.1%1 $6.39
5/15/202397,200 shares $422,820.00 -34.7%1.8%1.9 $4.35
4/30/2023148,900 shares $631,336.00 +30.6%2.6%3.1 $4.24
4/15/2023114,000 shares $386,460.00 +850.0%2.0%2.5 $3.39
3/31/202312,000 shares $65,988.00 -91.7%0.2%0.3 $5.50
3/15/2023144,400 shares $57,528.96 -45.3%0.2%0.3 $0.40
2/28/2023264,000 shares $145,200.00 +3.9%0.3%0.5 $0.55
2/15/2023254,200 shares $170,288.58 -13.0%0.3%0.5 $0.67
1/31/2023292,000 shares $197,859.20 -8.5%0.4%0.6 $0.68
1/15/2023319,000 shares $202,469.30 -23.6%0.4%0.6 $0.63
12/30/2022417,700 shares $164,949.73 +4.4%0.5%0.9 $0.39
12/15/2022400,000 shares $151,200.00 +61.4%0.5%1.1 $0.38
11/30/2022247,900 shares $125,189.50 -55.6%0.3%0.7 $0.51
11/15/2022558,300 shares $267,202.38 -5.7%0.7%1.7 $0.48
10/31/2022591,800 shares $320,518.88 +33.1%0.7%1.5 $0.54
10/15/2022444,800 shares $208,833.60 -41.7%0.5%0.8 $0.47
9/30/2022762,400 shares $357,870.56 +4.1%0.9%1.4 $0.47
You won't believe what Citigroup just did to it's depositors (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW
9/15/2022732,100 shares $427,766.03 +2.4%0.9%1 $0.58
8/31/2022714,800 shares $434,241.00 +25.2%N/A0.8 $0.61
8/15/2022570,900 shares $428,117.91 -44.6%0.7%0.6 $0.75
7/31/20221,030,000 shares $597,400.00 +14.6%1.2%1 $0.58
7/15/2022899,000 shares $557,380.00 -22.5%1.1%0.9 $0.62
6/30/20221,160,000 shares $678,600.00 -69.6%1.4%1.1 $0.59
6/15/20223,810,000 shares $2.30 million -10.4%4.5%3.4 $0.60
5/31/20224,250,000 shares $2.74 million +9.0%5.0%4.8 $0.65
5/15/20223,900,000 shares $2.70 million +3.2%4.6%4.5 $0.69
4/30/20223,780,000 shares $2.81 million +15.6%4.5%4.1 $0.74
4/15/20223,270,000 shares $2.81 million -14.6%4.0%3.3 $0.86
3/31/20223,830,000 shares $3.87 million -12.8%4.7%3.9 $1.01
3/15/20224,390,000 shares $3.35 million +16.1%5.8%4.5 $0.76
2/28/20223,780,000 shares $3.29 million -1.8%5.0%3.6 $0.87
2/15/20223,850,000 shares $3.93 million +3.2%5.1%3.4 $1.02
1/31/20223,730,000 shares $4.40 million +10.7%5.0%3.3 $1.18
1/15/20223,370,000 shares $5.06 million +13.1%9.9%3 $1.50
12/31/20212,980,000 shares $4.95 million +13.7%8.7%2.8 $1.66
12/15/20212,620,000 shares $4.90 million -3.0%7.7%2.4 $1.87
11/30/20212,700,000 shares $5.45 million -4.6%7.9%2.6 $2.02
11/15/20212,830,000 shares $6.54 million +2.9%8.3%2.9 $2.31
10/29/20212,750,000 shares $6.16 million -8.6%8.1%2.6 $2.24
10/15/20213,010,000 shares $6.89 million +2.4%8.8%2.9 $2.29
9/30/20212,940,000 shares $7.91 million -3.9%8.6%2.7 $2.69
9/15/20213,060,000 shares $8.32 million -39.6%9.0%2.6 $2.72
8/31/20215,070,000 shares $15.41 million +11.4%15.0%3.7 $3.04
8/13/20214,550,000 shares $12.42 million +15.2%13.5%2.9 $2.73
7/30/20213,950,000 shares $11.42 million +10.0%11.7%2.3 $2.89
7/15/20213,590,000 shares $10.55 million -10.5%10.6%2.1 $2.94
6/30/20214,010,000 shares $13.31 million +3.9%11.9%2.2 $3.32
6/15/20213,860,000 shares $13.78 million -17.5%11.5%2 $3.57
5/28/20214,680,000 shares $15.68 million +4.9%14.0%2.5 $3.35
5/14/20214,460,000 shares $12.04 million +6.2%13.3%2.2 $2.70
4/30/20214,200,000 shares $13.65 million -4.1%12.0%2 $3.25
4/15/20214,380,000 shares $13.93 million +13.8%12.5%1.7 $3.18
3/31/20213,850,000 shares $12.28 million +30.5%11.7%1.3 $3.19
3/15/20212,950,000 shares $10.12 million +9.7%9.0%0.9 $3.43
2/26/20212,690,000 shares $9.28 million -10.0%8.2%0.7 $3.45
2/12/20212,990,000 shares $13.19 million -11.8%9.1%0.8 $4.41
1/29/20213,390,000 shares $14.31 million -18.3%10.3%1 $4.22
1/15/20214,150,000 shares $19.55 million -19.6%12.6%1.3 $4.71
12/31/20205,160,000 shares $20.23 million -0.4%15.6%1.7 $3.92
12/15/20205,180,000 shares $13.99 million +14.1%15.8%2 $2.70
11/30/20204,540,000 shares $15.71 million +2.7%13.8%2.2 $3.46
11/15/20204,420,000 shares $13.48 million +3.0%13.4%2.8 $3.05
10/30/20204,290,000 shares $12.10 million +44.9%13.6%2.8 $2.82
10/15/20202,960,000 shares $9.44 million +33.3%9.4%2 $3.19
9/30/20202,220,000 shares $6.99 million +47.0%7.0%1.7 $3.15
9/15/20201,510,000 shares $5.72 million +39.8%4.8%1.2 $3.79
8/31/20201,080,000 shares $3.53 million +11.8%3.4%0.9 $3.27
You won't believe what Citigroup just did to it's depositors (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW
8/14/2020966,300 shares $2.99 million +28.4%3.1%0.8 $3.09
7/31/2020752,500 shares $2.32 million +38.9%2.4%0.7 $3.08
7/15/2020541,600 shares $1.70 million -9.1%1.7%0.6 $3.14
6/30/2020595,900 shares $1.89 million -43.3%2.1%0.8 $3.18
6/15/20201,050,000 shares $3.31 million +297.0%3.7%1.7 $3.15
5/29/2020264,500 shares $944,265.00 +9.3%0.9%0.7 $3.57
5/15/2020241,900 shares $679,739.00 -20.2%0.9%0.7 $2.81
4/30/2020303,300 shares $864,405.00 -19.0%1.1%1.2 $2.85
4/15/2020374,400 shares $1.11 million -28.0%1.3%1.5 $2.97
3/31/2020520,200 shares $1.46 million -22.5%1.7%1.7 $2.80
3/13/2020670,800 shares $1.81 million +0.4%2.4%3.2 $2.70
2/28/2020668,400 shares $1.40 million +2.2%2.4%2 $2.09
2/14/2020653,800 shares $1.78 million -3.9%2.4%1.8 $2.73
1/31/2020680,000 shares $2.17 million +8.2%2.5%2 $3.19
1/15/2020628,600 shares $2.40 million +2.9%2.3%1.8 $3.82
12/31/2019610,700 shares $2.42 million +9.1%2.2%1.8 $3.97
8/15/20191,013,700 shares $3.94 million -8.9%6.5%3.6 $3.89

MBIO Short Interest - Frequently Asked Questions

What is Mustang Bio's current short interest?

Short interest is the volume of Mustang Bio shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 247,200 shares of MBIO short. 2.73% of Mustang Bio's shares are currently sold short. Learn More on Mustang Bio's current short interest.

What is a good short interest percentage for Mustang Bio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.73% of Mustang Bio's floating shares are currently sold short.

Is Mustang Bio's short interest increasing or decreasing?

Mustang Bio saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 247,200 shares, an increase of 200.7% from the previous total of 82,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Mustang Bio's float size?

Mustang Bio currently has issued a total of 12,520,000 shares. Some of Mustang Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mustang Bio currently has a public float of 9,070,000 shares.

How does Mustang Bio's short interest compare to its competitors?

2.73% of Mustang Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mustang Bio: ABVC BioPharma, Inc. (6.77%), Vaxxinity, Inc. (3.61%), Aeterna Zentaris Inc. (0.53%), Oragenics, Inc. (2.07%), Chemomab Therapeutics Ltd. (0.88%), Alterity Therapeutics Limited (0.42%), NuCana plc (1.65%), Kintara Therapeutics, Inc. (2.04%), Vaccinex, Inc. (1.71%), Addex Therapeutics Ltd (0.69%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Mustang Bio stock?

Short selling MBIO is an investing strategy that aims to generate trading profit from Mustang Bio as its price is falling. MBIO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mustang Bio?

A short squeeze for Mustang Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MBIO, which in turn drives the price of the stock up even further.

How often is Mustang Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBIO, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:MBIO) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners